Corcept Therapeutics Incorporated (LON:0I3Q)

Corcept Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5,266	2,629	1,815	1,549	2,226	1,044
Market Cap Growth	57.59%	44.86%	17.14%	-30.41%	113.20%	-13.74%
Enterprise Value	4,839	2,303	1,483	1,184	1,903	843
Last Close Price	50.38	25.73	16.74	14.79	19.59	8.54
PE Ratio	50.24	31.74	21.59	18.64	28.67	14.68
PS Ratio	7.69	6.94	5.44	5.73	8.59	4.51
PB Ratio	7.57	6.61	4.36	5.58	5.81	3.73
P/TBV Ratio	7.57	6.61	4.36	5.58	5.81	3.73
P/FCF Ratio	33.91	26.38	18.23	12.53	20.16	10.24
P/OCF Ratio	33.43	26.35	18.17	12.49	20.00	10.16
EV/Sales Ratio	9.73	6.08	4.45	4.38	7.34	3.64
EV/EBITDA Ratio	41.67	27.08	15.69	12.73	20.18	9.94
EV/EBIT Ratio	42.67	27.34	15.86	12.88	20.26	10.01
EV/FCF Ratio	45.48	23.12	14.90	9.58	17.24	8.27
Debt / Equity Ratio	0.01	0.00	0.00	0.00	0.00	0.01
Debt / EBITDA Ratio	0.05	0.00	0.01	0.00	0.02	0.03
Debt / FCF Ratio	0.05	0.00	0.01	0.00	0.02	0.03
Asset Turnover	0.91	0.80	0.80	0.74	0.72	0.85
Inventory Turnover	1.26	0.94	0.97	1.07	1.08	1.08
Quick Ratio	3.51	4.07	6.60	5.31	9.86	7.64
Current Ratio	3.70	4.39	6.89	5.60	10.07	7.91
Return on Equity (ROE)	25.77%	21.05%	23.11%	25.03%	23.70%	29.11%
Return on Assets (ROA)	13.00%	11.13%	13.98%	15.63%	16.29%	19.27%
Return on Capital (ROIC)	16.18%	13.28%	16.01%	17.25%	17.80%	21.45%
Return on Capital Employed (ROCE)	21.79%	20.75%	22.04%	33.09%	24.45%	29.88%
Earnings Yield	1.99%	3.17%	4.64%	5.36%	3.49%	6.81%
FCF Yield	2.02%	3.79%	5.48%	7.98%	4.96%	9.76%
Buyback Yield / Dilution	1.56%	3.64%	7.94%	-1.42%	-1.33%	3.25%
Total Shareholder Return	1.56%	3.64%	7.94%	-1.42%	-1.33%	3.25%

Source: S&P Capital IQ. Standard template. Financial Sources.